TEVA TO COLLABORATE WITH PROCOGNIA

Teva Pharmaceutical Industries Ltd. and Procognia (Israel) Ltd. announced that they had reached a cooperation agreement on two biopharmaceutical products. Under the agreement, Procognia will supply Teva services and access to its proprietary glycoanalysis technology on an exclusive basis, and Teva will fund the costs of the collaboration and pay certain milestones and royalties to Procognia subject to pre-defined achievements relating to the usage of the technology in the development of the biopharmaceuticals. Globes (http://www.globes.co.il/serveen/globes/DocView.asp?did=1000135196&fid=1725)